Contraceptive prevalence, any modern method in Belgium
Belgium: Contraceptive prevalence, any modern method was 65.4% in 2018. ▲ Rising
Contraceptive prevalence, any modern method in Belgium, 1966–2018
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
Belgium recorded 65.4% for contraceptive prevalence, any modern method in 2018.
Compared with earlier readings it is down 10.2% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Belgium peaked at 74.3% in 1992 and was at its lowest, 10.8%, in 1966.
That places Belgium 20th out of 113 countries with data for 2018, putting it in the top quarter.
Contraceptive prevalence, any modern method in Belgium, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1966 | 10.8% | — |
| 1976 | 47.9% | +343.1% |
| 1983 | 63.2% | +32.0% |
| 1992 | 74.3% | +17.6% |
| 2010 | 72.8% | -2.0% |
| 2013 | 65.9% | -9.5% |
| 2018 | 65.4% | -0.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1960s | 10.8% | 10.8% | 10.8% | 1 |
| 1970s | 47.9% | 47.9% | 47.9% | 1 |
| 1980s | 63.2% | 63.2% | 63.2% | 1 |
| 1990s | 74.3% | 74.3% | 74.3% | 1 |
| 2010s | 68.0% | 65.4% | 72.8% | 3 |
Countries ranked near Belgium
More health data for Belgium
- Un projection of annual infant deaths, annual growth rate -3.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2923 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,160 deaths per 1,000 people (2090)
- Number of infants who die before age 1 59 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0229 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.96 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Belgium?
- Contraceptive prevalence, any modern method in Belgium was 65.4% in 2018, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Belgium?
- The highest recorded value was 74.3% in 1992.
- What is the lowest contraceptive prevalence, any modern method recorded in Belgium?
- The lowest recorded value was 10.8% in 1966.
- How does Belgium rank for contraceptive prevalence, any modern method?
- Belgium ranks 20th out of 113 countries with data for 2018.
- Is contraceptive prevalence, any modern method rising or falling in Belgium?
- Over the last ten years it is down 10.2%. The long-run trend across the full record is rising.
- Where does this Belgium data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.